A. Liang

发表

ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1

H. Moch, D. Hancock, J. Downward, 2014, Nature Cell Biology.

Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-κB activation, in hepatocellular carcinoma.

Xin Tong, Jian Zhao, Ya-jun Guo, 2010, Gastroenterology.

Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.

Xuetao Cao, Jun Guo, Yizhi Yu, 2004, Cellular & molecular immunology.

Epigenetic silence of ankyrin‐repeat–containing, SH3‐domain–containing, and proline‐rich‐region– containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus–positive hepatocellular carcinoma

Xin Lu, Lei Cao, Xin Tong, 2010, Hepatology.

Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma.

Li Lin, Zhengxin Wang, L. Qin, 2011, Cancer cell.

Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma

W. Cong, Xin Tong, Jian Zhao, 2008, Clinical Cancer Research.

Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma.

M. Zhang, Zhengxin Wang, T. Liang, 2014, Cancer cell.

Thirty‐kilodalton Tat‐interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma

W. Cong, Xin Tong, Jian Zhao, 2008, Hepatology.